USPTO serial 97898955
SPL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 9, 2024
- Examiner
- BONEN-CLARK, HOPE MICHELLE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SPL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products and preparations containing active pharmaceutical ingredients, namely, pharmaceutical grade Heparin Sodium, pharmaceutical grade Pancreatin, and pharmaceutical grade Pancrealipase, for use in humans for the prevention and treatment of thrombotic events and to treat pancreatic insufficiency and related diseases; Pharmaceutical products and preparations, namely, anticoagulants; pharmaceutical products and preparations for the testing, sampling and identification of viruses, namely, medical diagnostic reagents and assays for testing of body fluids; Chemical preparations for sanitary use; Chemical preparations for treating mildew; Diagnostic preparations for medical purposes; Injectable pharmaceuticals for treatment of anaphylactic reactions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for treating thyroid conditions; Pharmaceutical preparations for wounds; Diagnostic preparations for use with medical devices; Pharmaceutical preparations for treating thrombotic events and pancreatic insufficiency for use with medical devices for drug delivery; Pharmaceutical preparations for ophthalmological use, namely, for treating eye diseases and disorders; none of the foregoing for use with animals | ACTIVE | Jan 1, 1976 |
| 040 | Manufacturing services for others in a cGMP ("Current Good Manufacturing Practice") compliant facility in the field of therapeutic compounds, namely, the extraction, isolation and purification of naturally derived and fermentation-derived therapeutic compounds | ACTIVE | Jan 1, 1976 |
| 042 | Pharmaceutical contract development in a cGMP ("Current Good Manufacturing Practice") compliant facility in the field of therapeutic compounds, namely, the extraction, isolation and purification of naturally derived and fermentation-derived therapeutic compounds | ACTIVE | Jan 1, 2014 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Hepalink USA Inc.
- Other trademarks owned by Hepalink USA Inc.
- Other trademarks owned by Hepalink USA Inc.
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named SPL
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 9, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 9, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 12, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 12, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 12, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 12, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 4, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 3, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 3, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 28, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 17, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 24, 2023 | NWAP | NEW APPLICATION ENTERED | — |